Post Reports cover image

The promise of anti-covid pills

Post Reports

00:00

Intro

This chapter examines the rise in COVID-19 cases driven by the Omicron variant and the U.S. government's strategies, including enhanced testing and hospital support. It also sheds light on new antiviral pills from Pfizer and Merck, exploring their potential to mitigate severe illness, particularly among high-risk groups.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app